BioCardia (BCDA) Non-Current Debt (2020)
BioCardia's (BCDA) quarterly Non-Current Debt came in at $225000.0 in Q3 2020, down 19.93% quarter-over-quarter from $281000.0 in Q2 2020.
Powered by 
Analysis
BioCardia (BCDA) Non-Current Debt (2020) Analysis & Trends
BioCardia (BCDA) has reported Non-Current Debt for 1 consecutive years, with $225000.0 the latest figure, recorded in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | 586.20 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 50.15 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 100.26 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 93.88 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 847.62 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | - |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | - |